GlaxoSmithKline defends Avandia
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
520469
GlaxoSmithKline Plc is facing a number of lawsuits from U.S. parents of children and adolescents given its antidepressant Paxil, following claims the company suppressed data showing the drug increased suicidal tendencies in young people.
476254
GlaxoSmithKline Plc, Europe&#39;s largest drugmaker, said it settled a lawsuit filed by New York Attorney General Eliot Spitzer, who accused the drugmaker last June of withholding safety data on the antidepressant Paxil.
160485
The safety of GlaxoSmithKline Plc's controversial diabetes drug Avandia was attacked in a new analysis by German researchers on Wednesday, dealing a fresh blow to the group's second-biggest product.
264018
Drug maker GlaxoSmithKline's medical director said the company's study of the heart risk associated with its Avandia diabetes treatment may be in jeopardy because patients have dropped out following reports of the drug's risks, The New York Times reported on Saturday.
457535
Merck &amp; Co.&#39;s chairman and chief executive Raymond Gilmartin yesterday defended his firm&#39;s handling of earlier health warnings about Vioxx and said he
33756
Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements after a failed study generated negative publicity.
288970
LONDON (Agence de Presse Medicale) - GlaxoSmithKline on Tuesday defended trials of HIV (news - web sites) drugs in orphans, saying &quot;clinical trials involving children and orphans were legal and not unusual.
655501
GlaxoSmithKline Plc  faces a U.S. investor lawsuit claiming that Europe's biggest drugmaker misled shareholders about the safety of diabetes drug Avandia.
323348
GlaxoSmithKline Plc fired another salvo in defense of diabetes treatment Avandia on Tuesday by taking out full-page advertisements in at least a dozen major U.S. newspapers in an attempt to reassure patients of the safety of the widely used medicine.
69180
FDA commissioner Andrew von Eschenbach took a tongue-lashing from members of Congress over the way his agency handled Avandia, the diabetes drug from GlaxoSmithKline that has come under scrutiny for alleged heart attack risks.
268173
A U.S. Food and Drug Administration  preliminary analysis found a level of heart-attack risk with  GlaxoSmithKline Plc&#39;s  diabetes drug Avandia  similar to what was reported in a study earlier this week, the  agency confirmed on Friday.
203886
The maker of the controversial diabetes pill Avandia pointed to early results of its own study Tuesday, saying they offered reassuring evidence the drug doesn't raise heart risks. However, outside experts called the results inconclusive at best and a sign of greater risk at worst.
643165
GlaxoSmithKline shares fall sharply after US research links its diabetes drug Avandia to a higher risk of heart attacks.
1595
The pharmaceutical giant GlaxoSmithKline has agreed to settle consumer fraud charges by posting online both negative and positive results from its clinical drug trials, a practice that New York Attorney General Eliot Spitzer said should have been made
468296
Doctors in the United States have shunned GlaxoSmithKline Plc's diabetes drug Avandia since a study was published last week linking the drug to heart-attack risk, according to daily prescription data.
743041
Drugmaker GlaxoSmithKline agreed Thursday to settle charges that it hid and misrepresented unfavorable data about the effectiveness and safety of its top-selling anti